A new paradigm in prostate cancer drug and biomarker development
The Prostate Cancer Clinical Trials Consortium (PCCTC) is at the forefront of biotechnology research, dedicated to designing, implementing, and completing hypothesis-driven early-phase trials in prostate cancer. With a mission to translate scientific discoveries into improved standards of care, The Prostate Cancer Clinical Trials Consortium (PCCTC) offers comprehensive contract research organization (CRO) services. These services ensure efficient trial selection, meticulous reporting, expert site management, streamlined clinical operations, and in-depth data analyses.
Located in New York, NY 10065, US, The Prostate Cancer Clinical Trials Consortium (PCCTC) brings together distinguished investigators who collaborate to advance the field of prostate cancer treatment. The Prostate Cancer Clinical Trials Consortium (PCCTC)’s work is pivotal in driving progress and innovation in oncology.
The Prostate Cancer Clinical Trials Consortium (PCCTC) remains committed to pushing the boundaries of cancer research and providing cutting-edge solutions. We invite the manager of The Prostate Cancer Clinical Trials Consortium (PCCTC) to create a customized and exclusive company showcase and product listing on our platform, further highlighting their contributions to the biotechnology sector.
Le Prostate Cancer Clinical Trials Consortium (PCCTC) est à l'avant-garde de la recherche biotechnologique, se consacrant à la conception, à la mise en œuvre et à la réalisation d'essais de phase précoce axés sur des hypothèses dans le cancer de la prostate. Avec pour mission de traduire les découvertes scientifiques en normes de soins améliorées, le Prostate Cancer Clinical Trials Consortium (PCCTC) offre des services complets d'organisation de recherche contractuelle (ORC). Ces services garantissent une sélection efficace des essais, des rapports méticuleux, une gestion experte des sites, des opérations cliniques rationalisées et des analyses de données approfondies.
Situé à New York, NY 10065, États-Unis, le Prostate Cancer Clinical Trials Consortium (PCCTC) rassemble des chercheurs éminents qui collaborent pour faire progresser le domaine du traitement du cancer de la prostate. Le travail du Prostate Cancer Clinical Trials Consortium (PCCTC) est essentiel pour stimuler le progrès et l'innovation en oncologie.
Le Prostate Cancer Clinical Trials Consortium (PCCTC) reste déterminé à repousser les limites de la recherche sur le cancer et à fournir des solutions de pointe. Nous invitons le directeur du Prostate Cancer Clinical Trials Consortium (PCCTC) à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, soulignant davantage leurs contributions au secteur de la biotechnologie.
Compare The Prostate Cancer Clinical Trials Consortium (PCCTC) with 3 companies in Biotechnology-Research
| Comparison Field |
The Prostate Cancer Clini...Main Company |
SyncBio TechnologiesView Profile |
SpeciCare - The Lead...View Profile |
Leukaemia Research C...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2015 | 1992 |
|
Company Size
|
— | 2-10 | 11-50 | 11-50 |
|
City
|
New York, NY | Gainesville, Georgia | Newcastle upon Tyne, Tyne and Wear | |
|
Country
|
United States | United States | United Kingdom | |
|
Skills & Keywords
Comparing with main company
|
7 Total Skills
Biotechnology Research
Prostate Cancer
Clinical Trials
Oncology
Contract Research Organization
Cancer Research
Data Science
|
42 Total
42 Unique
Unique Skills:
ACMG
App Development
Artificial Intelligence
Bioinformatics
Biomedicine
Biostatistics
+36
|
25 Total
25 Unique
Unique Skills:
Before Cancer surgery
Cancer
Cancer Cure
Cancer Options
Cancer Vaccines
Chemo
+19
|
8 Total
8 Unique
Unique Skills:
Acute Lymphoblastic Leukaemia
Cancer
Cytogenetics
Cytogenomics
Immunotherapy
Machine Learning
+2
|
Other organizations in the same industry
This company is also known as